Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Fluorouracil × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 39 Stomach Neoplasms 19 Pancreatic Neoplasms 16 Rectal Neoplasms 13 Esophageal Neoplasms 12 Colonic Neoplasms 11 Adenocarcinoma Of Esophagus 10 Neoplasms 9 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 9 Squamous Cell Carcinoma of Head and Neck 8 Cholangiocarcinoma 7 Biliary Tract Neoplasms 5 Urinary Bladder Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Adenocarcinoma 4 Lung Neoplasms 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Anus Neoplasms 3 Advanced Solid Tumors 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Melanoma 2 Head and Neck Neoplasms 2 HER2-positive Gastric Cancer 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡